Robert McNamara

Robert McNamara, listed as board member, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in AVITA Medical, Inc., Axonics, Inc. and Xtant Medical Holdings, Inc. The record holds 22 filings, for trades running from 1 January 2016 to 20 January 2026.

No open-market sale appears; the market trades are 4 purchases worth €263k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 14 share grants and 2 option exercises.

In size, the median ticket on the buying side is €64k. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 4 June 2026, reports a share grant in AVITA Medical, Inc. The latest purchase dates back some time: it was published 415 days ago, on 29 August 2025. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.